Prudential customers now have access to ten cancer clinics, including a one-stop integrated cancer centre at Icon Cancer Centre Singapore

HONG KONG SAR – Media OutReach Newswire – 14 November 2024 – Prudential plc (“Prudential”) and Icon Cancer Centre Singapore (“Icon”) today announced a partnership that will provide Prudential’s health customers in Singapore and Indonesia access to outpatient cancer treatment, on a cashless basis[1], at Icon’s clinics in Singapore.

Treatments that are covered include chemotherapy, immunotherapy, targeted therapy, radiotherapy and surgical oncology*. In addition to prescribed cancer drugs, Icon’s clinics can provide Prudential customers with access to a team of leading oncologists and haematologists. Customers based in Singapore can also make use of Icon’s diagnostic screening facility. Prudential’s customers in Indonesia who wish to receive their treatment overseas can choose any preferred clinic from the Icon Cancer Centre network in Singapore without having to pay out of pocket.

In Southeast Asia, more than 2.3 million people are diagnosed with cancer each year¹. In Singapore, cancer incidence rates have risen by almost 28 per cent over the last 50 years². For Indonesia, the same trend is observed with a 17 per cent increase of new diagnoses from 2020 to 2022³.

“At Prudential, our focus is on providing affordable access to quality care for our customers. Receiving a cancer diagnosis can be life-changing and overwhelming, and questions about where to seek treatment and its cost only add to patients’ anxiety. Integrating Icon into Prudential’s preferred partnership network enables our customers to easily access a specialist cancer centre with proven expertise in treating many types of cancers without having to pay out of pocket,” said Arjan Toor, CEO, Health at Prudential plc.

“We have launched this partnership for the benefit of our customers in Singapore and Indonesia, two priority markets for our Health business, where we see growing demand for health insurance as well as an increasing volume of medical claims. We are looking to extend this access to other markets so more of our customers can benefit from high-quality cancer care,” said Toor.

“Icon is pleased to partner with Prudential to enhance access to high-quality cancer care, diagnosis, and treatment. Together, we are dedicated to making a lasting impact on cancer care and improving outcomes for patients. This partnership will help ease the burden for patients and their families, relieving some of the stress that comes with a cancer diagnosis and allowing them to focus on their treatment and wellbeing,” said Serena Wee, CEO, Icon Cancer Centre – ASEAN.

Notes:
*Diagnostics, drugs, and other services unrelated to outpatient chemotherapy and/or radiotherapy treatment will require payment at Icon Cancer Centre.
¹World Health Organisation
²National Registry of Diseases Office
³2020 World Health Organisation Cancer Country Profile and 2022 World Health Organisation Indonesia Factsheet
Hashtag: #Prudential #Icon

The issuer is solely responsible for the content of this announcement.

About Prudential plc

Prudential plc provides life and health insurance and asset management in 24 markets across Asia and Africa. Prudential’s mission is to be the most trusted partner and protector for this generation and generations to come, by providing simple and accessible financial and health solutions. The business has dual primary listings on the Stock Exchange of Hong Kong (2378) and the London Stock Exchange (PRU). It also has a secondary listing on the Singapore Stock Exchange (K6S) and a listing on the New York Stock Exchange (PUK) in the form of American Depositary Receipts. It is a constituent of the Hang Seng Composite Index and is also included for trading in the Shenzhen-Hong Kong Stock Connect programme and the Shanghai-Hong Kong Stock Connect programme.

Prudential is not affiliated in any manner with Prudential Financial, Inc. a company whose principal place of business is in the United States of America, nor with The Prudential Assurance Company Limited, a subsidiary of M&G plc, a company incorporated in the United Kingdom.

https://www.prudentialplc.com/

About Icon

Icon Group

Icon Group is Australia’s largest integrated provider of cancer care with a growing reach in New Zealand, Asia and the United Kingdom.

Icon is built on a strong but simple mission – to deliver the best care possible to as many people as possible, as close to home as possible. The group brings together all aspects of quality cancer care including medical oncology, haematology, radiation oncology, research, theranostics, pharmacy and compounding to deliver a truly integrated, end-to-end seamless service for cancer patients. With more than 3,500 team members, a network of more than 350 doctors, more than 45 cancer centres, six compounding facilities and operational support of 70 plus pharmacies, Icon is delivering world-leading care and helping address the global cancer burden.

For more information visit http://www.icongroup.global and follow Icon Group on LinkedIn at https://www.linkedin.com/company/icon-group

Icon Cancer Centre – Singapore

Icon Cancer Centre is a leading private cancer care provider delivering a holistic approach to cancer care. Icon Cancer Centre is part of Icon Group, a global cancer care provider with more than 45 centres globally. Icon Cancer Centre has six specialist clinics in Singapore and a dedicated health screening clinic. With a prominent and experienced team of medical oncologists, radiation oncologists, haematologists, paediatric haematologist-oncologists, palliative care specialists, general practitioners and visiting surgical oncologists, Icon provides end-to-end cancer care from screening and diagnosis, through to treatment and beyond.

For more information visit iconcancercentre.sg

Editor’s Note
Preferred clinics from Icon Cancer Centre:
1. Icon Cancer Centre – Mount Alvernia
2. Icon Nuclear Medicine and PET-CT Centre – Mount Alvernia Hospital
3. Icon Radiation Oncology – Mount Alvernia Hospital
4. Icon Surgical Oncology Centre – Mount Alvernia Hospital
5. Icon Cancer Centre – Farrer Park
6. Icon Cancer Centre – Gleneagles
7. Icon Cancer Centre – Mount Elizabeth
8. Icon Cancer Centre – Novena
9. Icon Cancer Centre – Orchard
10. Icon Haematology Centre – Mount Elizabeth

SHANGHAI, CHINA – Media OutReach Newswire – 14 November 2024 – HonKuwa Pharmaceutical Co., Ltd., Japan, made a significant debut at the 7th China International Import Expo (CIIE), presenting two new products—a plaster and a gel—designed to invigorate blood circulation, alleviate pain, and promote muscle and joint health.

Both products are formulated with extracts from mint and traditional Chinese herbal ingredients, crafted to be non-allergenic. They provide relief for 8 to 12 hours, effectively treating joint and muscle strains, offering a safe, natural, and effective solution for pain relief.

“This is our first appearance at the CIIE since entering the Chinese market,” said Yang Yuanzhuo, General Manager of HonKuwa Pharmaceutical in China.CIIE provides an open, innovative, and collaborative platform that allows us to showcase our concepts, services, and products. We hope that through this expo, more people will come to understand the natural, safe, and effective characteristics of HonKuwa’s products.”

Yang expressed optimism about the company’s expansion in China, stating, “The Chinese market is our largest in Asia, and we are confident in its growth potential. Since our entry in 2018, we have seen consistent, positive feedback from customers. We will continue to develop new products, enhance quality, and meet customer needs through both online and offline channels. Above all, quality and safety will remain our top priority.”

HonKuwa Pharmaceutical aims to further strengthen its position in China by meeting the demand for natural and effective pain relief solutions. Through continuous innovation and dedication to quality, HonKuwa is committed to improving the well-being of patients in China and beyond.

Founded in 2011, HonKuwa Pharmaceutical Co., Ltd. has focused on the import and export of health foods, medical products, and medical devices. In 2018, the company established a research and development team to create innovative and safe products. In 2022, the company launched its new brand, HonKuwa Pharmaceutical, which gained traction in Japan and expanded into the Chinese market in 2023, with multiple products entering Kumada Pharmacy in Osaka, Japan.

Hashtag: #HonKuwa

The issuer is solely responsible for the content of this announcement.

The US-based private capital software platform sets up base in Sydney as part of Investment NSW’s efforts to grow New South Wales into a thriving global hub for business.

SYDNEY, AUSTRALIA / SINGAPORE – Media OutReach Newswire – 14 November 2024 – Carta today announced its expansion into the Australian market, marking a significant milestone in the company’s roadmap to connect more startups and investors with its comprehensive private market ecosystem.

As startup companies scale and mature, their equity structures often become increasingly complex. In Australia, this complexity is amplified by factors such as ASX (Australian Securities Exchange) listing requirements, the intricacies of employee share schemes, and the corporate actions involved in growth, like mergers and acquisitions.

Australia, which is ranked 11^th on the Global Startup Ecosystem Index, boasts a robust economy and a growing demand for sophisticated solutions for the private market. To meet this need, Carta has chosen to expand its presence in the country. The expansion is supported by Investment NSW, a government agency dedicated to promoting economic growth and attracting investment to New South Wales.

Building on past successful projects with Australia-based firms such as Employment Hero and Titanium Ventures (formerly known as Telstra Ventures), Carta aims to collaborate with the government to deliver exceptional investment value to the local ecosystem. This aligns with the company’s commitment to Investment NSW’s goal of fostering local economic development. Carta’s prior investments in Australia included strategic partnerships for events and the establishment of a remote team.

Bhavik Vashi, Managing Director of Carta, will lead the company’s new initiatives in Sydney, bringing a wealth of industry experience from his background in B2B SaaS platforms serving the office of the CFO. His extensive experience and strong industry relationships will be instrumental in supporting Australian startups and funds as they navigate the complexities of the private market. His proven track record of scaling Carta’s operations in other markets, such as Singapore and the Middle East, positions him well to drive significant growth in Australia.

“With its vibrant ecosystem, Australia is ripe for the next phase of growth in the private markets,” said Vashi. “Our official expansion here aligns perfectly with Carta’s vision to streamline how private markets operate. By introducing our solutions, we aim to empower local startups and investors to manage ownership more efficiently and scale operations effectively.”

Sam Wheatley, Executive Director for Fostering Innovation at Investment NSW, also expressed excitement about Carta’s Australian expansion. “Australia is a strategic market for global growth, and we are delighted to have Carta onboard to help us drive growth and innovation in the local startup ecosystem,” said Wheatley.

Carta is set to launch its new office in Sydney on Monday, 18 November 2024. This will serve as a hub for sales, marketing, and future activities such as the expansion of the company’s partnerships with local universities, UNSW Founders & INCUBATE from The University of Sydney, as well as Techstars Tech Central Sydney Accelerator powered by the NSW Government, to extend its free equity management program, Launch.Hashtag: #carta

The issuer is solely responsible for the content of this announcement.

About Carta

Carta is a platform that helps people manage equity, build businesses, and invest in the companies of tomorrow. Our mission is to create more owners. We do this by unlocking the power of equity ownership for more people in more places.

Carta is trusted by more than 40,000 companies in more than 160 countries to manage cap tables, compensation, and valuations. Carta also supports more than 7,000 funds and SPVs, which together represent over $130B in assets under administration. Carta’s liquidity solutions have returned $15B to shareholders in secondary transactions. Today, Carta’s platform manages nearly three trillion dollars in equity for more than two million total stakeholders.

Companies and funds like Flexport, Tribe, and Harlem Capital build their businesses on Carta. The company has been included on the Forbes World’s Best Cloud Companies, Fast Company’s Most Innovative list, and Inc.’s Fastest-Growing Private Companies. For more information, visit carta.com.

MOSCOW, RUSSIA – Media OutReach Newswire – 14 November 2024 – SIBUR plans to offset the carbon footprint of the Russian delegation attending the UN Climate Change Conference (COP29) in Azerbaijan, making it the first internationally verified carbon-neutral delegation in the history of the conference.

The offset will be achieved using carbon credits generated through a climate project aimed at improving energy efficiency at SIBUR-Neftekhim. The credits will be withdrawn from the company’s account in the Russian Carbon Units Registry.

The carbon footprint will be calculated by Kept, while TÜV AUSTRIA Standards & Compliance will verify the carbon-neutrality claim. A certificate confirming the carbon offset will be published on the website of the UN Global Compact National Network. The process is being carried out with the support of the Federal Service for Hydrometeorology and Environmental Monitoring, which is facilitating the work of Russia’s delegation and working group.

“We welcome SIBUR’s initiative to offset the carbon footprint of Russia’s COP29 delegation. It is important that the process is as transparent as possible and involves international verification bodies that will confirm the delegation’s carbon-neutral status,” said Natalia Dorpeko, Executive Director of the UN Global Compact National Network.

SIBUR experts regularly play an active role in the conference’s business programme, sharing their expertise on climate-related issues, including on the best practices and technological solutions adopted by the company, approaches to climate risk management, as well as the results of their climate projects and carbon credit transactions.

The company has already completed eight climate projects, reducing its emissions by a total of 10.8 million tonnes of CO₂-equivalent emissions over the past 10 years. These initiatives have generated over 3.3 million tonnes of certified carbon credits that can be traded in both Russian and international markets. To date, SIBUR has concluded no fewer than 15 transactions involving carbon credits, enabling its customers and partners to reduce or fully offset the carbon footprint of their operations, products or events.

Hashtag: #SIBUR

The issuer is solely responsible for the content of this announcement.

KUALA LUMPUR, MALAYSIA – Media OutReach Newswire – 14 November 2024 – Adding exotic currency pairs to a portfolio is a popular way to get exposed to a wider variety of assets. These pairs, which include currencies from emerging markets or smaller economies, offer unique opportunities due to their volatility and potential for high returns. For traders in regions like India and Southeast Asia, exotic pairs can serve as valuable tools for diversification, potentially increasing returns from trading. Octa Broker, a broker with globally recognised licences, explains the basics of exotic pairs and provides tips on how to navigate such a dynamic landscape, where understanding volatility and managing risk is paramount.

Key characteristics of exotic currency pairs

Exotic currency pairs differ from major and cross pairs in several ways, each presenting opportunities as well as challenges for traders.

Higher spreads and lower liquidity
Exotic pairs tend to have wider spreads due to lower trading volumes and reduced liquidity. For instance, the USD/ZAR pair frequently experiences a spread of 100 pips or more, driven by its less active market presence. This wide spread is a broker’s commission for facilitating trades in less liquid markets, and it requires traders to account for this in their profit calculations to avoid unanticipated losses.

Volatility and economic sensitivity
Some exotic pairs exhibit strong trending behaviour, with notable examples like the USD/MXN (U.S. Dollar / Mexican Peso) pair. The USD/MXN pair often responds dynamically to economic factors, particularly commodity prices. As Mexico is a major oil exporter, fluctuations in oil prices can significantly impact the Peso’s value against the dollar.

While exotic currency pairs present exciting opportunities, a deep understanding of market drivers is essential when handling them. Traders must keep track of both local economic conditions and global trends to make informed decisions.

Kar Yong Ang, a financial market analyst at Octa broker, provides a glimpse into factors affecting the USD/MXN pair: ‘Currently, Mexico is experiencing a trade deficit, indicating that its imports exceed exports, which can place downward pressure on the peso and contribute to its weakening. Additionally, market participants are cautious about a potential U.S. recession, leading to an increased demand for the dollar as a safe-haven asset.’ This scenario demonstrates how closely linked economic developments are to the performance of exotic currency pairs, underscoring the importance of staying informed on both local and international factors when trading these pairs.

Strategies for trading exotic currency pairs

Exotic pairs demand a solid grasp of market conditions and robust risk management strategies. For beginners, using a smaller portion of their capital and setting realistic profit goals is essential. For example, they might start by trading small lot sizes in USD/ZAR and adjusting their stop-loss orders to manage risk in the face of potential large price movements. Here’s an example of fundamental and technical analysis a trader can make before opening a deal.

USD/ZAR (U.S. Dollar / South African Rand)
The USD/ZAR pair is influenced by South Africa’s economic conditions, political stability, and the fluctuating value of its key export, gold. With South Africa being a major gold producer, the currency often correlates with gold and platinum prices. When gold prices rise, the Rand typically strengthens, creating opportunities for traders who monitor commodity price movements closely.

Suppose a trader uses the Bollinger Bands indicator to identify buying and take-profit opportunities on USD/ZAR. Entering at 18.00 ZAR and exiting when it hits 18.80 ZAR, the trader secures an 8,000-pip profit, accounting for the 773-pip spread: the 8,000-pip difference excludes the spread. Normally, the spread is less than 100 pips, so the profit is secured. However, even in exceptional cases when the spread is higher, a trader can still seal a successful deal. This scenario highlights both the potential for profit and the importance of factoring in spread and volatility in trading strategies.

Advantages and risks of trading exotic currency pairs

Benefits of diversification
Adding exotic pairs to a portfolio can diversify risk due to the low correlation of these pairs with traditional assets like stocks and bonds, as well as major currency pairs. Since the exotic pairs include a popular currency and the one from a developing country, the determining factors that affect the price significantly differ from those impacting major pairs. This allows for a different set of trading opportunities.

Risks to consider
The high volatility and wide spreads of exotic pairs mean that traders must exercise caution. Without proper risk assessment, trading exotics can lead to significant losses. Monitoring local economic indicators and staying informed about global events are crucial for traders who wish to navigate these challenges successfully.

Exotic currency pairs offer intriguing opportunities for traders looking to explore beyond conventional assets. With their high volatility, unique correlation patterns, and sensitivity to both local and global factors, exotics provide an alternative avenue for diversification. By staying informed and applying sound strategies, traders can leverage the potential of exotic pairs while mitigating the associated risks.
Hashtag: #Octa

The issuer is solely responsible for the content of this announcement.

Octa

Octa is an international broker that has been providing online trading services worldwide since 2011. It offers commission-free access to financial markets and various services used by clients from 180 countries who have opened more than 52 million trading accounts. To help its clients reach their investment goals, Octa offers free educational webinars, articles, and analytical tools.